Science & Enterprise subscription

Follow us on Twitter

  • Four pharmaceutical companies are signing on to an initiative that promises to make clinical trials friendlier to p…
    about 6 hours ago
  • New post on Science and Enterprise: Pharmas Join Digital Clinical Trial Project #Science #Business
    about 6 hours ago
  • A robot device is being developed that can fly through the air and drive along the ground with a single motor, and…
    about 10 hours ago
  • New post on Science and Enterprise: Flying, Driving Drone Robot Unveiled #Science #Business
    about 10 hours ago
  • A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear…
    about 1 day ago

Please share Science & Enterprise

Follow by Email
Visit Us

In Case You Missed It …

(tigerlily713, Pixabay)

29 July 2018. Among our favorite stories on Science & Enterprise are when interesting science becomes a business opportunity. Last Wednesday, we reported on Convelo Therapeutics, a spin-off enterprise from Case Western Reserve University in Cleveland, commercializing research by its two geneticist founders that stimulate stem cells to replenish damaged myelin around nerve cells in the brain. Myelin is the waxy substance protecting nerve cells that gets destroyed by multiple sclerosis. The company emerged from stealth mode when the founders published papers in two Nature journals on Wednesday.

Here are other stories we covered last week:

*     *     *

Please share Science & Enterprise ...

Comments are closed.